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Campylobacter jejuni causes gastroenteritis in humans and is mainly acquired via 
consumption of contaminated poultry. C. jejuni is a frequent coloniser of chickens, often in 
the absence of overt pathology, yet produces a time- and magnitude- limited inflammatory 
response. One hypothesis is that glycosylation of surface moieties may mask the bacteria 
from recognition by the avian immune system, resulting in limited host responses. An O-
linked flagellin glycosylation island (Δcj1321-cj1325/6) has been previously shown to play a 
role in the colonisation of chickens. 
Previously described methods for generation of avian antigen-presenting cells (APCs) were 
applied and tested. The objective of this project was to investigate the interactions between 
chicken APCs and C. jejuni strains that vary in legioniminic acid substitution of the flagellum 
(Δcj1321-cj1325/6 and Δcj1324); Δcj1321-25/6 being a whole locus knock out, and Δcj1324 
being a single gene knockout.  
Primary bone-marrow derived APCs, macrophages (BMMs) and dendritic cells (BMDCs) 
were cultured for 6 days under standard conditions, then stimulated with either 
lipopolysaccharide (LPS, 100ng/ml), wild-type C. jejuni (11168H), mutant strains lacking 
genes responsible for flagellin O-glycosylation (Δcj1321-cj1325/6 and Δcj1324) (108 CFU/ml) 
for 4 hours. Stimulated cells were then harvested and RNA was extracted. Changes in mRNA 
expression of pro-inflammatory cytokine chIL--1β were quantified Taqman RT-qPCR assay. 
The mRNA expression levels of chIL-1β in BMMs, stimulated with mutant Δcj1321-cj1325/6 
were significantly decreased p=0.042; no significant effect in chIL-1β mRNA expression 
(p=0.989) in BMMs stimulated with mutant Δcj1324 when compared to those stimulated 
with the wild-type. 
The mRNA expression of chIL-1β in BMDCs, stimulated with the mutant Δcj1321-cj1325/6 
was decreased (p=0.052). BMDCs stimulated with the mutant Δcj1324 have displayed a 
significant decrease (p=0.013) in chIL-1β, when compared to wild-type stimulated control 
(11168H).  
Although the results presented are not conclusive of overall biological relevance, data 
appears to be indicative that C. jejuni flagellin O-glycosylation island may play a role in an 
immune response of chickens against C. jejuni, as there was notable decrease in expression 
levels of chIL-1β in both BMMs and BMDCs in response to the whole locus knock out mutant 
strain cj1321-25/6. This suggests that this locus might be important for host-bacteria 
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Chapter 1 - Introduction 
Campylobacter-a problem on global scale 
Genus Campylobacter consists of 16 species, majority of human infections (over 90%) are 
caused by Campylobacter jejuni and Campylobacter coli (Dasti et al. 2009). C. jeuni is a gram-
negative spirally shaped bacterium, found ubiquitously in the environment.  It is a major 
cause of human gastroenteritis in the developed world and has a significant financial 
impact, as it is estimated to be responsible for around 90% of hospital admissions due to 
food-borne illness in England and Wales in 2009 (FSA Chief Scientist report 2010-11). It is 
also a potentially life threatening infection (Young et al., 2007; Nyati et al., 2011). The 
symptoms of C. jejuni infection include bloody diarrhoea, vomiting, abdominal pain and 
fever, such symptoms usually self-limiting. Complications associated with C. jejuni may occur 
in some patients such as development of inflammatory bowel disease (Dasti et al. 2009) and 
autoimmune neuropathies such as Guillain-Barré and Miller Fisher syndromes which are 
caused by production of cross-reactive antibodies; it is estimated that approximately 1 in 
1000 patients would develop Guillain-Barré syndrome (Ang et al. 2002, Semchenko et al., 
2010; Hardy et al., 2011). Campylobacter infections have now replaced Salmonella 
infections as the leading cause of human gastroenteritis, and are still on the rise in Europe 
(scientific report of EFCA and ECDC, 2012). One of the main routes of acquiring the infection 
is via the consumption of contaminated poultry, with 60-80% of reported cases being due to 
poultry consumption. Up to 80% of retail poultry has been reported to be contaminated by 
C. jejuni (Zoonoses Report 2010). Control of Campylobacter colonisation in poultry is 
challenging, especially as legislation now prohibits the prophylactic use of antibiotics as 
growth promoters, which may have previously kept pathogen colonisation at lower 
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numbers (Dibner and Richards, 2005; Huyghebaert et al., 2010). There is therefore a need 
for alternative methods for infection control in chickens and other farm animals (Kaiser, 
2010; Huyghebaert et al., 2010). 
Campylobater in chickens, not a commensal.  
Campylobacter colonisation of chickens was long thought to be a commensal relationship 
and, unlike human infection, does not result in apparent pathology and is frequently 
asymptomatic (Shane, 1992; Hendrixson and DiRita 2004; Young et al., 2007; Bingham-
Ramos et al., 2008; Pajaniappan et al., 2008; Conlan et al., 2011). A number of exceptions to 
asymptomatic carriage exist, with a few reports of C. jejuni-associated neuropathies (Li et 
al., 1996; Nyati et al., 2011), association with avian vibronic hepatitis (Burch, 2005; Jennings 
et al., 2010), and the ability to cause diarrhoea and systemic infection in young chicks 
(Sanyal et al., 1984). A number of reports have shown that C. jejuni infections of chickens 
result in cytokine and chemokine production in chicken cell lines (Smith et al., 2005; 
Borrmann et al., 2007; Larson et al., 2008; Li et al., 2008) and in in vivo infection models 
(Smith et al., 2008), triggering the adaptive immune response (Huang et al., 2007; Shoaf-
Sweeney et al., 2008). Attachment to intestinal epithelial cells and Campylobacter invasion 
has been demonstrated (Byrne et al., 2006; van Deun et al., 2008; Hermanset al., 2011), 
along with invasion of deeper tissues such as liver and spleen (Hofreuter et al., 2008; van 
Deun et al., 2008). Furthermore it has been identified that some C. jejuni strains result not 
only in mild, but relatively severe pathology, such as prolonged intestinal inflammation, 
diarrhoea and inflammation associated pathology in legs and feet of the birds (Humphrey et 
al. 2014). Knowledge about the interactions between C. jejuni and specific components of 
the avian immune system is, however, limited. 
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Innate immune system and clearance of pathogens.  
The immune system is responsible for capture and clearance of pathogens and is 
superficially divided into two components, innate and adaptive. Innate immunity is 
responsible for the initial detection of pathogens and, in mammals, is performed by means 
of specific components: cells (neutrophils, macrophages, dendritic cells (DCs)), proteins 
(complement, antimicrobial peptides), pattern recognition receptors (PRRs) (Toll-like 
receptors (TLRs), retinoic acid inducible gene I (RIG-I)-like receptors (RLR), nucleotide 
oligomerization domain (NOD)-like receptors (NLR), and C-type lectin receptors (CLRs)) 
(Kawai and Akira, 2011; Wells et al., 2011).  
In chickens, antigen capture and presentation is performed by DCs and macrophages, and 
partially by thrombocytes and heterophils both of which phagocytose pathogens (Wu and 
Kaiser, 2010). Pattern recognition receptors such as TLRs and NLRs are present, although 
there are different repertoires of each, whereas RLR is absent from the genome (Kaiser, 
2010).  
Antigen presenting cells (APCs) of the immune system are the link between innate and 
adaptive immunity and are responsible for antigen capture, processing, and presentation to 
appropriate T cell subsets in order to activate a suitable adaptive response. DCs are 
professional antigen presenting cells. In mammals the common myeloid progenitor in bone 
marrow differentiates under the influence of various cytokines, notably granulocyte-
macrophage colony stimulating factor (GM-CSF) and macrophage colony stimulating factor 
(M-CSF or CSF-1) into naïve DCs and macrophages respectively (Gordon, 2003). 
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DCs in mammalian models were initially derived from bone-marrow progenitors (CD34+) 
using GM-CSF and interleukin-4 (IL-4) (Lardon et al., 1997). These cytokines were 
successfully cloned, characterised and expressed in the chicken (Avery et al., 2004), and 
subsequently used to generate and characterise chicken primary bone-marrow derived DCs 
(Wu et al., 2009).  Following the capture and processing of antigen, mammalian DCs 
undergo a maturation process as they migrate to lymph nodes, making them less efficient at 
capturing antigens but enabling them to present antigens and stimulate T cells (Banchereau 
and Steinman, 1998). Chickens do not possess lymph nodes, however chicken DCs still 
undergo maturation (Wu et al., 2009). Maturation of DCs results in morphological changes, 
and can be assessed by levels of expression of co-stimulatory molecules such as CD40 and 
CD86 (Banchereau and Steinman, 1998).  In chickens, as in mammals, CCR6 is expressed on 
primarily immature DCs, whereas CCR7 is expressed on mature DCs (Wu et al., 2011). 
Macrophages, like DCs, can be derived from the bone marrow progenitor CD34+ cells under 
the influence of M-CSF (CSF-1) or GM-CSF (Gordon, 2003). In chickens, the use of 
recombinant CSF-1 results in the growth of pure macrophage cultures from bone marrow 
precursors (Garceau et al., 2010). Macrophages phagocytose pathogens and subsequently 
present their antigens to cells of the adaptive immune system. After encountering 
pathogens, macrophages become activated and can produce a variety of antimicrobial 
molecules such as nitric oxide (NO), reactive oxygen species (ROS), scavenger receptors 
(which aid in phagocytosis), pro-inflammatory cytokines and chemokines, and co-
stimulatory molecules (Gordon, 2003). 
Interaction between host’s PRRs, such as Toll-like receptors (TLRs) and microbial pathogen-
associated molecular patterns (PAMPs) plays an essential role in an innate immune 
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response. TLRs are able to detect highly conserved PAMPs, such as flagella (Smith et al., 
2003) and lipopolysaccharide (LPS) (Kawai and Akira 2011, Kumar et al., 2011).  
Recognition of PAMPs by TLRs leads to activation of the Toll/IL-1 Receptor (Resistance) 
domain (TIR) of PPRs, which activates downstream signalling (O’Neill, 2008) (Figure 1). 
Generally TLR downstream signalling involves recruitment of adaptor protein myeloid 
differentiation factor 88 (MyD88) and various members of the interleukin-1 receptor 
associated kinase (IRAK) family, which in turn phosphorylate members of tumour necrosis 
factor receptor (TNFR)-associated factor (TRAF) family and the resulting cascades then 
activate the release of nuclear factor κB (NF-κB) from the inhibitor NF-κB kinase complex 
(IKK), which results in activation of NF-κB, and subsequent transcription of cytokines, 
chemokines and co-stimulatory molecules (Kawai and Akira, 2004). Signalling pathways of 
human TLRs are summarised in figure 1.1. Signalling pathways in chickens are present and 







Glycosylation of surface proteins by prokaryotes. 
Glycosylation is one of the most common post-translational modifications, originally only 
attributed to eukaryotic organisms, now has been discovered and described for prokaryotes 
(Nothaft and Szymanski 2010). This process involves a covalent attachment of carbohydrate 
molecule to an amino acid (Valguarnera et al. 2016). Different types of bacterial 
glycosylation, which differ in the bond formed to form glycoproteins, these include O-linked: 
which involves attachment hydroxyl oxygen of serine or threonine (Ser/Thr) to 
carbohydrate; N-linked, which involves amide nitrogen of asparagine (Asn) linkage to 
carbohydrate; S-linked – attachment to the sulfur of cysteine (Cys), C-linked (C-
mannosylation) an attachment α-mannopyranose to tryptophan (Trp) through a C–C linkage 
and surface layer (S-layer) protein glycosylation – covalent linking of glycans  to surface of 
extracellular proteins (Schäffer  and Messner 2017, Nothaft and Szymanski 2010,Tan et al. 
2015). 
Glycosylation has an important role in many of bacterial functions, such as adhesion, cell 
charge and protein stability (Howard et al. 2009, Tan et al. 2015). Bacterial glycosylation has 
also been associated with antigenic diversity in bacterial pathogens, avoiding of detection 
by TLRs. The glycosylation in eukaryotic organisms plays an important role for innate and 
adaptive immunity (van Kooyk and Rabinovich 2008), some bacterial species have 
developed an ability to mimic or use the host glycans like sialic acid (Rabinovich et al. 2012), 
and furthermore human commensal Bacteroides spp can use host derived glycans for more 
exclusive relationships (Tytgat and Lebeer 2014). Other roles for glycosylation include 




Campylobacter immune evasion strategies.  
Campylobacter spp have an array of well-described immune evasion strategies. Variation of 
surface s-layer sugars has been helping immune evasion (Thompson 2002). A typical 
bacterial LPS consists of lipid A, core oligosaccharide, and O chain polysaccharide. C. jejuni 
surface LPS consists of lipid A and inner regions of core oligosaccharide (Penner and 
Aspinall, 1997; Morgan, 2010), and is referred to as lipooligosaccharide (LOS), some 
bacterial species LOS often replaces LPS, to avoid host immune response, generated against 
O-antigen or detection by TLR4 (Trent et al., 2006; van Mourik et al., 2010; Shin et al., 2006; 
Barquero-Calvo et al., 2007; Duerr et al., 2009; Wolfe et al., 2009).  
C. jejuni possesses both types (N- and O- linked) glycosylation (Szymanski et al. 2003), which 
is present in various cellular components. Carbohydrate synthesis in C. jejuni has been 
associated with many cellular processes (Guerry and Szymanski, 2008), such as flagella 
assembly (Ewing et al., 2009, Chaban et al. 2015), furthermore genes, associated with 
flagellin glycosylation can undergo a phase variation (Tan et al. 2015), which can attribute to 
immune evasion and affect serospecificity (Howard et al. 2009). The pgl gene (responsible 
for N-glycosylation) been associated with glycosylation of at least 45 different proteins, and 
has been associated with periplasmic and outer membrane proteins (Mahdavi et al. 2014), 
disruption of N-linked glycosylation in C. jejuni has reduced its ability to attach and invade 
cells in vitro and reduced capacity for colonisation (Szymanski et al. 2003). Genes 
responsible for O-linked glycosylation are adjacent to flagellin structural genes FlaA and FlaB 
(Guerry and Szymanski, 2008), resulting in heavy glycosylation of flagellin; up to 19 sites in 
each FlaA monomer decorated in O-linked carbohydrates figure 1.2 (Logan et al. 2006, 
Chaban et al. 2015) Over 40 genes have been identified, which fell into non-livestock and 
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live-stock associated clades, and the locus 1321-25/6 has been among these 40 genes. Gene 
locus 1321-25/6, has been identified to also encode for O-glycosylation of C. jejuni flagella 
(Howard et al. 2009). Removal of entire gene locus 1321-25/6, did not result in loss of 
motility, but has resulted in decreased autoagglutination and hydrophobicity, furthermore 
both entire gene locus 1321-25/6 knock out and removal of single gene from the locus 
(Δ1324) have resulted in low-level colonisation of avian intestine, when compare to the 
wild-type strain (Howard et al., 2009). 
Evasion of the innate immune system by C. jejuni is presumably a complex process, which 
possibly involves a number of interactions between the innate system and the bacterium on 
the molecular level however it has been hypothesised that locus 1321-25/6 aids the 
immune evasion in chicken host, which allows high level persistent colonisation. 
Improvement of our understanding of chicken colonisation by C. jejuni may be useful in 
vaccine development strategies, lowering the colonisation levels in chickens and improving 






Objectives of the thesis 
The main objectives of this project have been divided in to two categories: establishing a 
functional in vitro model for investigation of C. jejuni interaction with chicken’s immune 














Chapter 2 – Materials and Methods 
2.1. In vitro materials and animals 
2.1.1 Cell lines 
2.1.1.1 Routine maintenance and growth of COS-7 cells. 
COS-7 cells were obtained from liquid nitrogen stocks, from Kaiser laboratory -80 °C storage 
and revived in the COS-7 growth medium (Dulbecco’s Modified Eagle Medium 
supplemented with 10% heat-inactivated foetal calf serum (Gibco), 1% L-glutamine, 1% non-
essential amino acids.). 
Routine maintenance of COS-7 cells involved passaging cells once confluent (at least 95%). 
Cells required trypsinisation in order to be split them into new flasks. Old tissue culture 
medium was discarded and cells were washed twice with 10 ml pre-warmed phosphate 
buffered saline (PBS), followed by a wash with 5 ml of trypsin/versene (1:8-1:10) solution. 
Trypsin/versene (5 ml) was added to cells and incubated at 37°C for 4-5 min. The flask was 
tapped on a bench to remove any adherent cells, and then 15 ml of complete medium was 
added to inhibit the activity of trypsin. Cells were pelleted by centrifugation at 1000 x g for 5 
min. The supernatant was discarded and cells were re-suspended in 10 ml of medium, 
counted and seeded into T75 flasks at 7.5 x 105 cells/ml. 
2.1.1.2. Transfection of COS-7 cells for production of recombinant chicken cytokines (IL-4, 
GM-CSF and CSF-1). 
Transfection was performed using a DEAE/Dextran method. The day before the transfection, 
COS-7 cells were seeded at 6x106cells per T75 flask and incubated for 18-24 h at 37°C in 5% 
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CO2 until 80-90% confluence is reached. Serum free DMEM (2.5 ml) was added to a bijoux, 
followed by addition of Endofree plasmid DNA (52 µg) and DEAE/dextran (15 µl) in that 
order and mixed well. COS-7 cells were then washed twice by removing media and adding 
PBS (5 ml), repeated twice. After the wash step DNA/DEAE complex was added to the cells 
and incubated for 30-60 min at 37°C in 5% CO2, and swirled occasionally to prevent drying 
out of the cells. DMEM + 10% FBS (10 ml) was mixed with chloroquine (100 µl) was added to 
the COS-7 cells and flask returned to incubator for 2-3 h at 37°C in 5% CO2. Following 
incubation, cells were washed by removing the medium and adding PBS (5 ml), followed by 
the addition of DMSO (10% in PBS, 10 ml) and incubated further incubation at RT for 2 min. 
Cell supernatant was then removed and replaced with DMEM +10% FBS and incubated or 
16-24 h at 37°C in 5% CO2. Following this incubation, the medium was removed and 
replaced with DMEM. If the transfection was performed for the production of recombinant 
cytokines, the supernatant from the transfected cells was collected after 3-5 days post 
media change, centrifuged at 500 x g for 5 min and collected into a fresh universal/falcon 
tube and stored at 4 °C 
2.1.2 Bacterial cells  
2.1.2.1. Escherichia coli. 
JM109 is competent E.coli, purchased from Promega UK. 
2.1.2.2 Campylobacter jejuni. 
A number of campylobacter strains were used in this study. Wild-type strains include avian 
isolate strains 11168H (Jones et al. 2004), 81-176 and M1. Previously described mutant 
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strains of 11168H were used for stimulations Δ1324, Δ1321-25/6, Δ1321-25/6 repaired) 
(Howard et al. 2009). 
2.1.3. Birds 
Outbred lines of chickens, in order to attempt the Brown legnorn and J-line birds were used 

















2.2. In vitro methods 
2.2.1. Culturing Campylobacter jejuni.  
Strain confirmation 
Initially wild-type and mutant strains were cultured from the glycerol stocks on CCDA plates 
for 48 hours under microaerophilic conditions; this was followed by selecting a single colony 
and re-suspending the bacterial cells in 5 ml of MH broth supplemented with Trimethoprim 
and cultured in the shaker (400rpm) under microaerophilic conditions for 48 hours 
Campylobacter strains were cultured on CCDA plates (supplemented with Trimethoprim (5 
µg/ml) and Kanamycin (15 µg/ml) (not for wild-type 11168H) for 48 h under microaerophilic 
conditions. A single colony of each strain was selected for a starter culture (5 ml) of MH 
broth supplemented with Kanamycin (not for wild-type strain of 11168H) and Trimethoprim 
and left in the shaker under microaerophilic conditions for 24 hours. Following incubation, 
starter culture (5 ml) was poured into 100ml of MH broth supplemented with Kanamycin 
(not for wild-type strain of 11168H) and Trimethoprim and left in the shaker under 
microaerophilic conditions for further 48 hours. 
Fixation of C. jejuni  
Bacterial cell were then harvested by centrifugation 2000x g for 10 min, the pellets were re-
suspended in 4% paraformaldehyde (PFA) and left to fix for 2 hours, cells were then washed 
with filtered (using 0.2 µm pore size filter) 0.15 M NaCl five times (2000 x g for 5 min). For 
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control, unfixed cells, live bacterial cells were subjected to the same wash steps as fixed 
cells. Bacterial cells were then counted using bacteria counting kit (Invitrogen). 
2.2.1.1.Bacteria counting  
Bacterial cultures were serially diluted to approximate concentration of 106 cells/ml, and 1.0 
mL volume of cell suspension  was used per assay. Diluted cells were stained by adding 1 µL 
of SYTO® BC bacterial stain (Component A) and incubated at 37°C for 30 min, it was then 
mixed with microsphere standard suspension (Component B, 10 µL). The resulting mixture 
was used to enumerate bacterial concentration using flow cytometry analysis (FACSCalibur 
(BD)). 
Bacterial cultures and microspheres (beads) were gated in separate gates; quantifying the 
signal in the microsphere gate (beads gate) provided accurate estimate of the volume 
analysed in the run. The microsphere standard contains 108 beads per mL; following the 
addition of the microsphere standard to the bacterial mixture, microsphere density was 
106beads/mL and one bead represented 10-6 mL. The number of signal in the bacterial gate 
divided by the number of signal in the beads gate provided the number of bacteria per 10-6 
of the sample. 
2.2.2. Avian primary antigen presenting cells. 
2.2.2.1. Collection and morphological characterisation of bone-marrow derived dendritic 
cells (BMDCs). 
Femurs and tibias of 3-6 weeks old birds were removed and isolated from the surrounding 
muscle tissue using sterile instruments. Bones were placed into universals in PBS.  Both ends 
of the bones were cut off and each bone was washed with PBS using a 10 ml syringe and 21 
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G needle. The cell suspension was passed through 40 µm nylon cell strainers, and then 
washed with PBS. Re-suspended cell suspension was overlaid over an equal amount of 
Histopaque 1.077 (kept at RT) and centrifuged at 1200 x g for 30 min (at RT) with no brakes. 
Cells at the interface between PBS and Histopaque 1.077 were collected and washed twice 
with PBS. Cells were re-suspended in PBS, counted and adjusted to a final concentration of 
106 cells/ml. Recombinant chicken cytokines (generated as described in 2.1.1.2) were used 
for cell differentiation. Recombinant chicken IL-4 (1:250, - 12µl of cytokine added to each 
3ml well) and GM-CSF (1:1000, -3µl of cytokine added to each 3ml well) were added to 
induce differentiation into DCs. 
2.2.2.2 Generation and morphological appearance of bone-marrow derived macrophages 
(BMM). 
The process followed was the same as for the dendritic cells above. Once cells were 
adjusted to a final concentration of 106 cells/ml, recombinant chicken CSF-1 (1:200) was 
added to induce macrophage differentiation - 5µl of cytokine added to each 1ml well 
2.2.2.3. Harvesting of BMMs and BMDCs for future analysis 
Primary macrophages and dendritic cells were harvested using EDTA post stimulation. Using 
Pasteur pipette 1 drop of 5.0M of EDTA (pH8) was added per 1 ml of media. Cells were then 
gently pipetted up and down to collect all the cells and were pelleted by centrifugation at 
500 x g for 5 min for subsequent RNA isolation or flow cytometry staining procedures. 
2.2.3. Nucleic acid extraction  
2.2.3.1. Large scale (maxi) plasmid DNA preparation. 
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DNA preparation was performed using an EndoFree® Plasmid Purification kit (Qiagen) 
according to the manufacturer’s instructions. Fresh bacterial starter cultures were streaked 
from glycerol stocks onto LB agar plates, supplemented with 100 µg/ml of ampicillin 
(LB/Amp100) and cultured overnight at 37°C. On the next day, a single colony per culture was 
re-suspended in LB/Amp100 (5 ml) and cultured at 37°C for 8 h with shaking at 180 rpm to 
produce a seeder culture. Next, LB/Amp100 was inoculated with 250-500 µl of seeding 
culture and incubated overnight at 37°C with shaking at 180 rpm. Overnight culture was 
then distributed between five 50 ml Falcon tubes and cells were pelleted by centrifugation 
at 3000 x g for 60 min at 4°C. Cells were re-suspended in a lysis buffer (1 ml) and collected 
into one falcon tube. A second lysis buffer P2 (10 ml) was then added to cell lysates and 
mixed by pippeting and incubated for 20 min at RT; Neutralisation buffer P3 (10 ml) was 
added to the lysates and mixed by inverting until protein-genomic DNA complex is visible. 
The lysates were then centrifuged at 3500 x g for 5 min at 4 °C. Supernatant from cell 
lysates was then transferred to a QIAfilter Cartridge, incubated for 10 min and filtrated into 
new 50 ml Falcon tube. Buffer ER (2.5 ml) was added to the filtrate and incubated on ice for 
30 min. Filtered lysates were then added to an equilibrated (with buffer QBT) QIAGEN-tip 
column, left to enter the column by gravity and then washed with buffer QC (2 x 30 ml). 
DNA was eluted with buffer QN (15 ml) into fresh Falcon tube and precipitated by 
isopropanol (10.5 ml). DNA was pelleted by centrifugation at 3000 x g for 60 min at 4°C. 
Supernatants were discarded, pellets washed with ethanol (70%, 5 ml) and centrifuged at 
3000 x g for 10 min at 4°C. Supernatant was then discarded and any remaining liquid 
removed using p10 Gilson pipette, pellet were left to air dry at room temperature for 5 min 
and re-dissolved in endotoxin-free TE buffer (250 µl). The DNA was quantified using a 
Nanodrop-1000 spectrophotometer , selecting DNA-50 option in the nucleic acids section. 
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2.2.3.2. RNA extraction  
Initial steps for RNA extraction differed, depending on the origin of the sample. 
Tissue extraction from chicken pancreas  
Fresh tissue was homogenised with a rotor-stator homogeniser with 600 µl of buffer RLT. 
The lysate was then centrifuged at full speed and the supernatant transferred to a 
microcentrifuge tube.  
Cell culture extraction 
Macrophages or DCs, were harvested by addition of EDTA 5M (pH 8.0) centrifuged at 500 x 
g for 5 min at 4 °C, supernatant discarded, RLT buffer (350 µl) added and mixed by pipetting.  
Further extraction steps 
Once the lysate was produced, .one volume of 70% ethanol was added to the lysate and 
mixed by pipetting, and 700 µl of the sample were then transferred to an RNeasy spin 
column which was placed in a 2 ml collection tube and centrifuged at 8,000 x g for 15 s. The 
flow-through was discarded, and this step was repeated if the sample size was greater than 
700 µl. This was followed by addition of 700 μl of buffer RW1 to the RNeasy spin column, 
and centrifuged at 8,000 x g for 15 s to wash the spin column membrane. The flow-through 
was discarded. To wash the spin column, 500 µl of buffer RPE (containing 4 volumes of 96% 
ethanol) were added and centrifuged at 8,000 x g for 15 s. Flow-through was discarded, and 
this step was then repeated with 2 min centrifugation at 8,000 x g. The column was then 
placed into a fresh collection tube and centrifuged for 1 min at full speed to remove any 
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carryover of buffer RPE. The spin column was then placed into a 1.5 ml microcentrifuge tube 
and RNA was eluted with 40 µl of RNase-free water and centrifuged at 8,000 x g for 1 min.  
2.2.4. Quantitative and non-quantitative amplification of nucleic acids 
2.2.4.1.Polymerase chain reaction 
Phusion High-Fidelity DNA Polymerase (Thermo Scientific, F-530S) was used to amplify the 
DNA, collected from C. jejuni cultures. PCR reaction volumes: 5x Phusion HF Buffer (10 µl), 
dNTP mix (dATP, dGTP, dCTP and dTTP at 10 mM, 2 µl), gene-specific forward primer (10 
mM, 5 µl), gene-specific reverse primer (10mM, 5 µl), template cDNA (~50 ng, 1 µl), Phusion 








2.2.4.2. Agarose gel electrophoresis 
Agarose gel electrophoresis was performed to visualise the PCR products. PCR product (5 µl) 
was added to 1 µl of 6x loading buffer (1x final concentration), and electrophoresed on 0.7% 
agarose gels at 110 V for 1.5 h. Agarose gels were prepared by dissolving 0.42 g of agarose 
powder in 70 ml of Tris-acetate-EDTA (TAE) buffer, and adding 7 µl of 10000x SYBR® Safe gel 
stain. All products were visualised using a G-Box Imager. DNA ladders (promega 1kb and 
100bp; Generuler – Thermo scientific) were used to estimate product sizes. 
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2.2.4.3. Real-time quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) 
(TaqMan assay). 
Real-time qRT-PCR was used to measure the level of chicken cytokine interleukin-1β (chIL-
1β) and chemokine (CXCLi2) mRNA expression in chicken DCs and macrophages. This 
method has been described previously (Swaggerty et al.,2008; Wu et al., 2009). Expression 
levels of chIL-1β and CXCLi2 mRNA were measured alongside those of a reference gene, 28S, 
for every sample. The 28S encodes for a ribosomal RNA component, and is constitutively 
expressed in all eukaryotic cells, and is therefore often used for standardisation of the target 
gene quantity (Swaggerty et al. 2008). To measure mRNA expression of 28S, chIL-1β and 
CXCLi2 probes and primers from Sigma were used (Table 2.1). Standard probes were 
labelled at the 5’end with 5- or 6- carboxyfluorescein (FAM) fluorophore, and at the 3’ end 
with tetramethylrhodamine (TAMRA) quencher dye. The close proximity of the reporter 
fluorophore and the quencher allows the quencher to inhibit the fluorescence of the 
reporter dye (to the low level of background fluorescence). During the PCR reaction, the 
probe anneals to the template between the forward and reverse primers. While the 
template being amplified reaches the bound probe, the 5’-3’ endonuclease activity of Taq 
degrades the probe, resulting in release of the reporter away from close proximity with the 
quencher, producing fluorescence. The level of fluorescence observed is directly 
proportional to the amount of PCR product in the reaction. The results were collected at the 
cycle threshold (Ct) value, representing the number of cycles at which fluorescence was 
detected above a threshold value. 
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A typical reaction contained FAST Universal Master Mix (5 µl), primer mix (at optimal 
concentration (Table 3), 0.5 µl), probe (0.25 µl), multiscribe enzyme (40x, 0.25 µl), nuclease-
free water (1.5 µl), and template RNA (2.5 µl). Template RNA for test samples was diluted 
1:500 for 28S and 1:5 for cytokine analysis. Standard curves were obtained from serial 
dilutions of mRNA from LPS-stimulated HD11 cells (previously stimulated avian macrophage 
cell line, which has been used as a standard; concentrations used 10-2-10-6 for 28S and 10-1-
10-6 for chIL-1β and CXCLi2). Amplification and detection were performed using an Applied 
Biosystems 7500 Fast Real-Time PCR system.  





To account for technical and biological variation, the Ct values for chIL-1β and CXCLi2 mRNA 
expression were normalised against the Ct value of the 28S RNA product for the same 
sample. Standard plots of Ct against log10(RNA) were obtained for chIL-1β, CXCLi2 and 28S 
RNA. Normalised Ct values were calculated using the formula Ct+(N’t – C’t)*S/S’, where N’t is 
the mean Ct for 28S RNA among all samples, C’t is the mean Ct for 28S RNA in the sample, S 
is the slope of the regression of the standard plot for the chIL-1β and CXCLi2  mRNA and S’ is 
the slope of the regression of the standard plot for the 28S RNA. Results are expressed as 






































AJ245728 0.4 mM 
CXCLi2 Probe (FAM)- GCCCTCCTCCTGGTTTCAG-(TAMRA) 
F TGGCACCGCAGCTCATT 
R TCTTTACCAGCGTCCTACCTTGCGACA 
AJ009800 0.6 mM 
Table 2.1 Taqman primers. Real-time quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) 









Chapter 3 - Results 
3.1. Introduction. 
Previous studies, which have focused on understanding interaction between chicken 
immune system and wild-type C. jejuni species by colonisation studies (Jones et al. 2004, 
Smith et al. 2008, Howard et al. 2009) and by using in vitro models  and cells like chick 
kidney cells (CKCs), HD11 avian macrophage cell line (Smith et al. 2005), LHM -chicken 
hepatocellular carcinoma epithelial cells (Larson et al. 2008) or epithelian cells (Byrne et.al 
2007). 
Wild-type C. jejuni strains, which have been investigated in previous studies include 
“chicken specific strain” 11168H (Jones et al. 2004) and  “human specific strain” 81-176 
(Larson et al. 2008).  
Following advances in the field of chicken immunology we can now use more appropriate in 
vitro models. Protocols are now available to generate primary bone-marrow derived 
dendritic cells and described by Wu et al. 2009; similarly, protocols of how to obtain primary 
bone-marrow derived macrophages have also been described (Garceau et al. 2010). This 
chapter describes use of these protocols to generate primary chicken antigen presenting 
cells(APCs): bone-marrow derived dendritic cells (BMDCs) and bone-marrow derived 
macrophages (BMMs) and establishing a cell culture model to investigate mechanisms by 
which C. jejuni interacts with chicken’s immune.  
The aim of the experiments, described in this chapter was to confirm the generation of 
distinguished cell populations (BMMs and BMDCs) and establish them as an in vitro model 
for investigating interations between C. jejuni and APCs. 
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3.2. Materials and methods. 
BMMs and BMDCs were genenerated and cultured,bone marrow collected from same birds 
was pooled together (2.2.2.1 and 2.2.2.2), both BMMs and BMDCs were cultured for six 
days prior to stimulation. Bacterial culture of C.jejuni was cultured as described previously 
(2.2.1) and bacterial numbers were adjusted using bacteria counting kit as described in 
(2.2.1.1). Post-stimulation, both BMMs and BMDCs were harvested using EDTA (2.2.2.3), 
RNA extracted (2.2.3.2) and analysed for expression of chIL-1β using Taqman qRT-PCR 
(2.2.4.3). 
3.3. Results  
Morphological appearace of dendritic cells. 
Primary cells were cultured for 6 days in the presence of recombinant chicken IL-4 and GM-
CSF (41°C, 5% CO2). After 6 days, cells were viewed under the light microscope (Figure 3.1), 
cells have developed typical morphological appearance - have irregular shape, some are 
detached and are forming clumps of cells on top of the monolayer,  as previously described 
in Wu et al., 2009. 
Morphological appearance of macrophages  
Primary cells, cultured for 6 days in the presence of the CSF-1 (41°C, 5% CO2) were viewed 
under a light microscope. Appearance of cells observed - “fried egg” appearance with 
extensive dendrites and round cell aggregates on top (Figure 3.2), which is confirmed to be a 










Stimulations of BMMs and BMDCs with different concentrations of Lipopolysaccharide (LPS). 
After 6 days of growth, cells were stimulated with LPS in order to establish optimum 
concentration for use as a positive control. Cells were stimulated with different 
concentrations of LPS (50 ng/ml – 400 ng/ml) for 2, 4 or 6 hours for macrophages and 2 or 4 
hours for dendritic cells (at 41°C, 5% CO2). Cells were harvested post stimulation using EDTA 
(2.2.2.3), mRNA was extracted (2.2.3.2), and analysed for expression of chIL-1β cytokine 
using Taqman qRT-PCR (2.2.4.3). 
The mRNA expression of chIL-1β in BMMs and BMDCs in response to LPS stimulations was 
higher for both BMDCs and BMMs, when compared to un-stimulated control (Figure 3.3). It 
was however evident that this up-regulation of chIL-1β mRNA expression in these 







Stimulations of primary BMMs and BMDCs with various C. jejuni strains and concentrations. 
BMDCs and BMMs were generated and cultured as described previously, bone marrow 
samples were collected from six different birds, bone marrow from same birds was pooled 
together (2.2.2.1 and 2.2.2.2 respectively). Following six days of culture, BMMs and BMDCs 
were stimulated with wild-type C. jejuni strains: M1, 81-176 and 11168H at 107 and 108 
bacteria per ml for 4 hours at 41°C, 5% CO2. Cells were harvested post stimulation using 
EDTA (see section 2.2.2.3); mRNA was extracted from BMDCs and BMMs as described in 
section 2.2.3.2. Collected mRNA samples were analysed for expression of chIL-1β and 
CXCLi2 cytokines using Taqman qRT-PCR (as described in section 2.2.4.3). 
The mRNA expression of chIL-1β from BMMs, stimulated with C. jejuni wild-type strains 81-
176 and 11168H was increased, in comparison with a non-stimulated control, there was no 
apparent increase in chIL-1β expression in response to stimulation with M1 wild-type strain  
(Figure 3.4). Observed mRNA expression levels of CXCLi2 have expressed similar pattern of 
chIL-1β.  
The mRNA expression of chIL-1β and CXCLi2 from BMDCs, stimulated with C. jejuni wild-type 
strains 81-176, M1 and 11168H increased, when compared to non-stimulated control. In 
this experiment, observed results suggest that mRNA expression not affected by C. jejuni 












The mRNA expression levels of chIL-1β in primary BMMs and BMDCs, simulated with two 
different batches of same C. jejuni strain. 
BMM and BMDCs were cultured as previously described (2.2.2.1 and 2.2.2.2 respectively). 
Two different batches of C. jejuni were cultured and fixed in PFA as previously described; 
and bacterial numbers were established, and bacterial numbers were adjusted to 108 
bacteria per ml, and then cells were stimulated with C. jejuni wild-type strain 11168H at 108 
bacteria per ml for 4 hours at 41°C, 5% CO2. BMMs and BMDCs were harvested (2.2.2.3), 
RNA extracted (2.2.3.2) and analysed for expression of chIL-1β using Taqman qRT-PCR 
(2.2.4.3).There was no apparent difference between mRNA expression levels of chIL-1β in 
response to different batches (data not shown). 
Comparison of mRNA expression levels of chIL-1β in primary BMMs and BMDCs, simulated 
with live and fixed and fixed C.jejuni. 
BMM and BMDCs were cultured as previously described (2.2.2.1 and 2.2.2.2 respectively). 
Same batch of C. jejuni was cultured as previously described; and fixed in PFA as previously 
described; and bacterial numbers were established, and bacterial numbers were adjusted to 
108 bacteria per ml, and then cells were stimulated with C. jejuni wild-type strain 11168H at 
108 bacteria per ml for 4 hours at 41°C, 5% CO2. There was no notable difference in mRNA 
expression levels of IL-1β in response to bacteria fixed in PFA 4% and non-fixed bacteria 






3.4. Discussion  
In this chapter we have used current tissue culture models in an attempt to mimic the in 
vivo interactions between innate chicken cells and bacterial cells, and have optimised the 
experimental procedures in order to establish a functional in vitro model for further 
understanding of bacteria-host interaction in chickens. 
Primary BMDCs and BMMs were cultured as previously described, their morphological 
appearance resembled  the published description (Garceau et al. 2010, Wu et al. 2009). 
BMDCs and BMMs were then stimulated with lipopolysaccharide (LPS), in our experiments 
there was no noticable difference in mRNA expression levels of chIL-1β in response to 
different concentrations of LPS (50, 100, 200 and 400 ng/ml), in previous studies LPS 
concentration used was 200ng/ml (Wu et al., 2009). Using previous literature and observed 
results we have concluded that use of 100ng/ml was acceptable in future experiments.  
Use of fixed bacteria when compared to use of non-fixed bacteria of the same strain on 
APCs did not affect the mRNA expression of chIL-1β and, therefore used in future 
experiments. 
Different batches of the same strain of C. jejuni did not result in different expression of chIL-
1β. These results have confurmed that use of different batches was indded acceptable for 
future experiments.  
Wild-type strains of C. jejuni have generally displayed an increase in production of of chIL-1β 
and CXCLi2, however the 11168H strain was chosen for future exeriments as it is a parent 





This experimental chapter provided adequate preliminary information which is used to set 
up the main experiments as described in the next chapter. Phenotypes of both BMDCs and 
similar to previously described.  














Chapter 4 - Results  
4.1. Introduction 
C. jejuni is a frequent coloniser of chickens gastrointestinal tract and is able to colonise in 
hight numbers, producing a limited immune response (Smith et al. 2008). Campylobacter 
jejuni strain 11168H has been shown to colonise chickens efficiently in previous studies 
(Jones et al. 2004). A cluster of genes 1321-25/6 was found to this cluster of genes was 
prevalent in live-stock campylobacter isolates, especially chickens (Champion et al. 2005), 
these genes are responsible for O-linked glycosylation of flagellin in C. jejuni.  
Glycosylation has been previously shown to be an important factor for colonisation ability of 
C. jejuni (Jones et al. 2004). It has also been illustrated, that mutant strains Δ1324 and 
Δ1321-5/6 were not able to colonise chickens as efficiently as wild-type strain. It has be 
hypothesised that more efficient immune response against mutants with altered ability for 
O-glycosylation might be due to a more efficient immune response being mounted against 
C. jejuni (Howard et al. 2009). 
In this chapter we have attempted to investigate this hypothesis by stimulating chicken 
BMDCs and BMMs with wild-type 11168H and mutant strains derived from it: ΔflaA – 
mutant strain completely lacking flagella (Jones et al. 2004); Δ1321-25/6 and Δ1324, 






4.2. Materials and Methods 
To investigate the responses of chicken antigen presenting cells to Campylobacter jejuni, 
BMDC and BMM were cultured from J-line birds as described previously (2.2.2.1 and 2.2.2.2 
respectively).  
BMDCs and BMMs were stimulated with media, 100ng/ml of LPS, and 108 bacteria per ml 
(enumerated as described previously 2.2.1.1) of C. jejuni 11168H and it’s mutant strains 
(Δ1234, Δ1321-25/6 (and it’s repair mutant), ΔFlaA) for 4 hours at 41°C, 5% CO2.  
To reduce technical variation each stimulation assay contained each own control cells, 
which included unstimulated (negative control), stimulated with 100 ng/ml of LPS (positive 
control) and wild-type C. jejuni (11168H strain positive control). 
Post-stimulation, RNA from BMDCs and BMMs was collected (2.2.2.3 and 2.2.3.2) and 
expression levels of chIL-1β were measured using Taqman qRT-PCR (2.2.4.3). Data were 
then presented as corrected 40-Ct and statistically analysed for significant differences 
between treatments using paired t-test. Five different birds were used to bone marrow for 
generation of BMMs and four different birds were used to bone marrow for generation of 








4.3. Results  
Changes in mRNA expression levels of chIL-1β in avian APCs in response to stimulation with 
cjΔ1321-1325/6. 
Expression levels of chIL-1β mRNA in primary chicken BMDCs and BMMs, following 
stimulation with knock out mutant of the Δ1321-1325/6 locus (Howard et al., 2009) and a 
repaired strain of Δ1321-1325/6 locus are summarised in the figure 6.  
BMMs stimulated with Δ1321-25/6 mutant strain have shown a significant decrease 
(p=0.042) when compared with the mRNA expression levels of chIL-1β in BMDCs, stimulated 
the wild-type C. jejuni control (11168H). The chIL-1β mRNA expression levels were increased 
when BMMs were stimulated with repair mutant of Δ1321-25/6, but is not statistically 
significant (p=0.139), when compared to mRNA expression of chIL-1β observed in response 
to mutant strain Δ1321-25/6 stimulation figure 6.  
BMDCs, stimulated with Δ1321-25/6 mutant strain have displayed a tendency for decreased 
mRNA expression levels of chIL-1β (p=0.052) when compared with the mRNA expression 
levels of chIL-1β in BMDCs, stimulated the wild-type C. jejuni control (11168H). The mRNA 
expression levels of chIL-1β in BMDCs, stimulated with a repair strain of Δ1321-25/6 was 
restored to levels, similar to ones observed in stimulation with wild-type C. jejuni strain 










Changes in mRNA expression levels of chIL-1β in avian APCs in response to stimulation with 
C. jejuni ΔFlaA mutant strain 
Changes in mRNA expression levels in BMMs and BMDCs in response to smilulation with 
knock out mutant of the flagellin component A – ΔflaA (Jones et al. 2004) to are summarised 
in the figure 4.2. 
BMDCs, stimulated with with C. jejuni knock out mutant of the flagellin component A – 
ΔflaA, have not displayed any significant decrease (p=0.552) in mRNA expression of chIL-1β 
when compared with the mRNA expression levels of chIL-1β in BMDCs, stimulated the wild-
type C. jejuni control (11168H) (figure 4.2). 
Similarly BMMs stimulated with C. jejuni knock out mutant of the flagellin component A – 
ΔflaA, have not displayed any significant decrease (p=0.503) in mRNA expression of chIL-1β 
when compared to the mRNA expression levels of chIL-1β in BMMs, simulated with the 














Changes in mRNA expression levels of chIL-1β in avian APCs in response to stimulation with 
cjΔ1324 
Changes in mRNA expression of chIL-1β in primary chicken BMDCs and BMMs, in response 
to stimulation with C. jejuni knock out mutant Δ1324 (Howard et al. 2009) are summarised 
in the figure 4.3.  
Stimulation of BMMs with Δ1324 mutant strain of C. jejuni has resulted in non-significant 
decrease (p=0.989) in mRNA expression of chIL-1β, when compared to the mRNA expression 
levels of chIL-1β in BMMs, simulated with the wild-type C. jejuni control (11168H) figure 4.3. 
The expression levels of chIL-1β mRNA levels in BMDCs were significantly decreases 
(p=0.013), when compared to the mRNA levels of chIL-1β in BMDCs, when compared to the 
mRNA expression levels of chIL-1β in BMDCs, simulated with the wild-type C. jejuni control 
















Stimulation of BMMs and BMDCs with ΔFlaA mutant strain did not result in a significant 
decrease in mRNA expression of chIL-1β, interestingly this mutant strain has also failed to 
colonise chickens 7 days post infection (Jones et al. 2004) This could be indicative that lack 
of flagellin assembly might not be an important factor for production of chIL-1β mRNA in 
avian APCs. Flagellin mutants have been shown to reduce their colonisation ability in 
chickens. The use of ΔFla A mutant strain was interesting as both Δ1324 and Δ1321-25/6 are 
genes responsible for flagellin, these data suggest that observed changes in mRNA 
expression levels of chIL-1β are not triggered by flagelin interaction with APCs. Interestingly, 
C. jejuni was also not able to activate NF-κB via chicken TLR5 (de Zoete et al. 2010). 
Expression levels of chIL-1β mRNA in BMDCs was significantly decreased when stimulated 
with mutant strain Δ1324, in comparison with mRNA levels of chIL-1β observed in to the 
wild-type stimulation.  
Decrease in mRNA of chIL-1β was not significant in BMMs stimulated with with mutant 
strain cjΔ1324, compared to the wild-type, however there has been a significant decrease in 
mRNA expression levels of chIL-1β, stimulated with the same strain (cjΔ1324), when 
compared to BMDCs stimulated with wild-type C. jejuni. It is unclear what causes the 
difference in responses between BMDCs and BMMs.  
Significant decrease in IL-1β mRNA has been obsereved in BMMs post stimulation with 
cjΔ1321-25/6 when compared to the wild-type. Notable, but not statistically significant 
decrease in IL-1β mRNA has been obsereved in BMDCs post stimulation with cjΔ1321-25/6 
when compared to the wild-type. Interestingly, both BMDCs and BMMs have displayed a 
50 
 
decreased mRNA expression levels of chIL-1β in response to cjΔ1321-25/6, in this case the 



















Chapter 6 - Discussion 
Rationale of the work and Importance of this project on the global scale. 
C. jejuni is a major cause of bacterial gastroenteritis in the developed world, furthermore, 
there are serious complications associated with C. jejuni infections in the form of 
neuropathies Guillain-Barré syndrome and Miller Fisher syndrome (Ang et al. 2002) 
Understanding of initial campylobacter colonisation, is important, as it  may be an important 
factor requied for establishment of high colonisation levels of C. jejuni in chickens. Reducing 
colonisation numbers in chickens would increase effectiveness of farm biosecurity 
measures, which would, in turn reduce the reservoir for human infection (Kaiser, 2010; 
Huyghebaert et al., 2010). 
The immune response is a complicated process; it is vast and involves many outputs from 
both innate and adaptive immune cells. In this project we have attempted to elucidate the 
mechanisms involved in initial recognition of the Campylobacter jejuni by the macrophages 
and dendritic cells, and factors, which might be relevant for the persistent C. jejuni 
colonisation in chickens. Primary avian BMDCs and BMMs were chosen as they were 
previously described and were easily reproducible, furthermore both did not involve large 
numbers of experimental animals (unlike for heterophil generation). Both macrophages and 
dendritic cells are involved in antigen presentation and are often first ones to be in contact 
with pathogen. The activation of innate immune response will in turn lead to the heterophil 
infiltration of the site of the infection (Smith et al. 2009). Justification of concentrations, 
time points and strains.  
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As in previous research published by Smith et al. 2005, we have used points for the initial 
immune response to LPS at 2, 4 and 6 hours. However, in order for most consistent 
response to C. jejuni and positive control (LPS) has been observed at 4 hours post 
stimulation.  
Using the parafolmaldehyde (PFA) to fix bacterial cells prior to the stimulation has enabled 
us to ensure that bacterial population does not change in the course of the experiment 
additionally changes in the oxygen concentrations would have altered the “state” (coccoid 
appearance) of the bacterial cells (Smith et al. 2016, Oh et al. 2015). Concentration selection 
was determined by producing serial dilutions of C. jejuni suspension and stimulating for 4 
hours. Biological significance of these observations however has not been confirmed as, 
avian macrophages or dendritic cells have not been described to be in contact with such 
high concentration of bacterial cells per an immune cell.  
We have investigated the response to different wild-type strains of C. jejuni to illustrate the 
difference in the response produced. Ability of different strains of C. jejuni to elicit a varied 
immune responses avian APCs, is in accordance with previous studies (Humphrey et al. 
2014). The effect produced by APCs in response to different wild-type strains was not 
pursued further as wilt-type strain 11168H is a parent strain to all of the mutant strain we 
have used and was used as a wild-type control in the subsequent experiments.  
APC response to stimulation with mutant C. jejuni strain ΔFlaA. 
Both BMMs and BMDCs have not displayed a decrease in mRNA expression of chIL-1β in 
response to flagellin knock out mutant ΔFlaA, it is hypothesised that flagellin per se may not 
be important in the immune detection of Campylobacter by chicken APCs, unlike in the 
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bacterial species, Campylobacter flagellin does not appear to be highly immunogenic and 
has been described to not be by both chicken and human TLR5 (de Zoete et al. 2010), and 
has lack of binding sites for hTLR5 (Guerry and Szymanski, 2008). Similarly Helicobacter 
pylori flagellin proteins are not detected by TLRs in mammals (Amieva and El-Omar 2008). 
However the flagellin cap protein FliD have been demonstrated to be important for cell 
binding in mammalian cells (Freitag et al. 2017). 
APC response to stimulation with mutant C. jejuni strain Δ1321-25/6 and Δ1324 
Both BMMs and BMDCs have displayed a decrease in chIL-1β production in response to 
stimulations with both Δ1321-25/6 and Δ1324, both of these mutant strains have displayed 
a reduced ability to colonise avian gut, resulting in low level persistence, unlike the wild-
type strain (Howard et al. 2009). Similarly, altering the flagellin O-glycosylation in 
Pseudamonas species has resulted in decrease in production of human IL-8, when compared 
to stimulation with wild-type strains (Verma et al. 2005). 
The biological relevance of reduced chIL-1β production might lay in the function of 
glycosylation itself. Glycosylation might not only be important in masking the bacterial 
surface to avoid detection, it has also been demonstrated in an initiation of immune 
response (Tan et al. 2015), it is possible that locus 1321-1325/6 of C. jejuni, is important in 
initial interaction with immune system, which leads into raising a response, which is not 
sufficient for clearance of C. jejuni which may enable high-level persistent colonisation 
Salmonella (Tsolis et al. 2008) and human pathogen H. pylori can elicit both 
proinflammatory and immunosuppressive effects in human stomach, it is hypothesised that 
it induces a robust but specific form of chronic inflammation that is ineffective in clearing 
the infection, while avoiding forms of inflammation that would eliminate it (Amieva and El–
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Omar 2008). It is possible that this strategy was initially adapted by now commensal 
bacteria, which are inducing low level inflammation in the gut, yet are not cleared, and can 
rapidly spread, human gut commensals are able to colonise in high numbers and persist for 
long periods of time. The glycosylation of Bactroides spp is also important for colonisation 
ability for its biological niche (Fletcher et al. 2009). 
Pro-biotic bacteria in human gut (Thomas and Versalovic 2010) decreased IL-1β and other 
pro-inflammatory cytokines by modulating the signalling pathways such as NF-κB in gut 
epithelial cells, as well as promote survival and musin secretion and factors to help 
induction of “gut homeostasis”. C. jejuni seems to be initiating a long term inflammation in 
the guts of the chicken; interestingly the birds, which were more successful at clearance of 
the C. jejuni have displayed an induction of regulatory (anti-inflammatory) responses, such 
as IL-10 and Tregs (Humphrey et al. 2014).  
Previous studies of Salmonella spp have confirmed that altering glycosylation the pathogen 
and makes it more “detectable” by intestinal epithelial cells, wild-type strain have display in 
activation of intestinal epithelial cells, but not macrophages (Durr et al. 2009). 
For example inflammation leads to vasodilatation and may result in “leaky gut” which will 
increase the nutrient supply; it may also assist in elimination of competitive species. This 
suggests that C. jejuni has adapted to avian immune system and is able to manipulate to 
avoid the clearance, resulting in high levels of persistence. The main aim of pathogen is to 
survive, so inducing devastating immune response which, will result in the death or serious 
impairment of the host will not benefit the bacteria, instead manipulating the immune 
response, in order to allow high level, persistent colonisation and rapid spread, results in the 




Limitations of this model and what could have been improved, for example use of 
experimental birds which are specific-pathogen free (SPF), non-vaccinated inbred line birds, 
that share same MHC as in studies by (Smith et al. 2008 Howard et al. 2009, Wu et al. 2009, 
Jones et al. 2004), would have possibly resulted in more universal response, therefore 
producing more clear data as the data we have collected had high standard deviation both 
between positive control (LPS) and bacterial stimulations. Some birds have been producing 
higher fold of mRNA, other much smaller. 
There is evidence that reactive nitrogen species also contribute to the clearance process of 
C. jejuni in human host (Iovine et al. 2008) similarly iNOS production was induced in CKC and 
HD11 cells (Smith et al. 2005). It has also been identified that C jejuni resistant birds produce 
B cell mediated response to clear the infection Connell et al. 2012  Possibly a full micro array 
would be beneficial to pin point exact interaction between C. jejuni and its avian host and 
compare the results observed in wild-type and mutant strains.  
Future studies.  
Bacteria-host interaction is an active process changes in the environment are picked up by 
bacteria and would lead to change in surface expression various molecules as host provides 
a “stressful environment” (Lebeer et al. 2010), the reversible changes in gene expression are 
common in bacteria, including C. jejuni  (Tan et al. 2015). It has been identified that variation 
in rowth temperature (37°C and 42°C) can influence Campylobacter metabolism (Stintzi, 
2002; Khanna et al., 2006; Young et al., 2007; Baserisalehi and Bahador, 2011) and LOS 
production (Semchenko et al., 2010). 
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Additionally cross-talk between carbohydrate modification pathways of C. jejuni may have 
additional role (Guerry and Szymanski 2008), identifying genes involved during colonisation 
may aid in identifying factors important in the clearance of C. jejuni by chickens, using a 
ligated-loop model would have allowed collection of both bacterial for analysis and 
collection of chicken cells involved in the response and observe the presence of cell types 























This project has, hopefully given a deeper insight into the processes involved in detection of 
C. jejuni by the immune system of chickens in addition to expanding our understanding of 
importance of O-glycosylation of flagella. 
Immune recognition and manipulation of responses by C. jejuni will need a further 
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Composition of buffers and solutions  
 
Buffer composition Endo free maxi kit 
Buffer P1 (resuspension buffer) 50 mM Tris·Cl, pH 8.0;  
10 mM EDTA;  
addition of 100 μg/ml RNase A  
Buffer P2 (lysis buffer) 200 mM NaOH,  
 
1% SDS (w/v) 
 
Buffer P3 (neutralization buffer) 3.0 M potassium acetate, pH 5.5  
Buffer QBT (equilibration buffer) 750 mM NaCl;  
50 mM MOPS, pH 7.0; 
15% isopropanol (v/v); 
0.15% Triton® X-100 (v/v) 
 
Buffer QC (wash buffer) 1.0 M NaCl;  
50 mM MOPS; 
15% isopropanol (v/v), pH 7.0. 
 
Buffer QN (elution buffer) 1.6 M NaCl; 15–25°C 
50 mM MOPS, pH 7.0; 
15% isopropanol (v/v) 
 
TE 10 mM Tris·Cl, pH 8.0;  
1 mM EDTA 
 
Gel extraction 




Dissolve 8g NaCl, 0.2g KCl, 1.44g Na2HPO4 and 0.24g KH2PO4 in 800ml of distilled water. 
Adjust to pH 7.4 with HCl. Add water to 1 liter. Dispense into aliquots. Sterilize by 
autoclaving. 
FACS buffer  
PBS/BSA/Az 
2X Rapid Ligation Buffer, T4 DNA Ligase (provided) 
60mM Tris-HCl (pH 7.8)  
20mM MgCl2  
20mM DTT  
2mM ATP  
10% polyethylene glycol 
TAE (50X) 
242g Tris base  
37.2g Na2EDTA•(2H2O) in 900ml of deionized water.  
Supplemented with 57.1ml of glacial acetic acid, and adjusted the final volume with water 
to 1 litre.  
BigDye® dilution buffer  
250mM Tris-HCl (pH 9.0) 
10mM MgCl 
X-Gal  
Dissolve 100mg X-Gal in N, N′-dimethylformamide to a final volume of 2ml. Dispense into 
500µl aliquots, and store protected from light at –20°C. The final concentration of X-Gal is 
50mg/ml.  
IPTG  
Dissolve 1.2g IPTG (isopropyl-β-d-thiogalactopyranoside) in deionized water to a final 
volume of 50ml. Filter sterilize (0.2µm), and store in 5ml aliquots at –20°C. The final 
concentration of IPTG is 0.1M 
Agarose gel sample buffer (6X)  
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Dissolve 4g sucrose and 2.5mg bromophenol blue in 6ml of TE buffer [10mM Tris-HCl (pH 
8.0), 1mM EDTA]. Once dissolved, bring up to a final volume of 10ml with TE buffer 
0.5M EDTA (pH 8.0)  
Add 186.1g disodium ethylenediamine tetraacetate•2H2O to 800ml of water. Stir vigorously 
on a magnetic stirrer. Adjust the pH to 8.0 with NaOH. EDTA will slowly go into solution as 
the pH approaches 8.0. Dispense into aliquots, and sterilize by autoclaving. 
1M dithiothreitol (DTT)  
Dissolve 3.09g DTT in 20ml of 0.01M sodium acetate (pH 5.2). Sterilize by filtration. Dispense 
into 1ml aliquots, and store at –20°C. 
Versene (Gibco®) 
This is EDTA solution for use as a gentle non-enzymatic cell dissociation reagent. Versene 
Solution (0.48 mM) is formulated as 0.2 g EDTA (Na4) per liter of Phosphate Buffered Saline 
(PBS). 
Accutase 
100 ml, ready to use, frozen sterile liquid. 1X ACCUTASE enzymes in Dulbecco's PBS (0.2 g/L 
KCl, 0.2 g/L KH2PO4, 8 g/L NaCl, and 1.15 g/L Na2HPO4) containing 0.5 mM EDTA·4Na and 3 
mg/L Phenol Red. 
10X PCR Buffer (Invitrogen Taq Cat: 18038-034)  
200 mM Tris-HCl (pH 8.4) 
500 mM KCl  
Bacteria counting kit  
Saline (NaCl) 0.15 M, 1 ml of 5 M NaCl in 29 ml of H20 
5% LB in Saline – 2.5 ml of LB broth (see above) into 47.5 ml of 0.15 M NaCl 
MULTI-CORE™ 10X Buffer 250mM Tris-acetate (pH 7.8 at 25°C), 1M potassium acetate, 
100mM magnesium acetate and 10mM DTT. 
SOB Medium (per litre) 
20.0 g of tryptone 
5.0 g of yeast extract 
0.5 g of NaCl 
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Deionised water was added to a final volume of 1 L then autoclaved 
Filter-sterilised 1M MgCl2 (10 ml) and 1 M MgSO4 were added prior to use. 
SOC medium (per 100 ml) 
Filter-sterilised 2 M glucose (1 ml) was added to SOB (see above) to a final volume of 100 
ml. 
LB Agar (per Litre)  
10 g of NaCl 
10 g tryptone 
5 g of yeast extract 
20 g of agar 
Deionised water was added to make a final volume of 1 L. 
pH adjusted to 7.0 using 5 N of NaOH and then autoclaved. 
Ampicillin 100 
Dulbecco’s Modified Eagle Medium (DMEM)  
With 4500 mg/L glucose, L-glutamine and sodium bicarbonate and with pyridoxine 
(substitutes pyridoxine HCl for pyridoxal HCl) 
Supplemented with 10%  heat-inactivated foetal calf serum (Gibco), 1% L-glutamine, 1% 
non-essential amino acids. 
RPMI-1640 
With 25 mM HEPES and sodium bicarbonate,  
Supplemented with: 1% L-glutamine, 1 U/ml of penicillin and 1 µg/ml of streptomycin  
10% chicken serum (for DC cultures)/10% foetal bovine serum (PAA, for macrophages),  
Mueller-Hinton broth  
Typical Formula gm/litre  
Beef, dehydrated infusion from  300.0  
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Casein hydrolysate  17.5  
Starch  1.5  
pH 7.3 ± 0.1 @ 25°C 
 
 
